Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunization (FMAIG) - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunization

MONDO:0019068

Also known as:FMAIGalloimmune neonatal renal diseasefetomaternal alloimmunization with antenatal glomerulopathies

Overview

A glomerular disease characterized by severe renal failure and nephrotic syndrome at birth, which rapidly improve in the first weeks of life.

Patient Orgs2 organizations · Maternal Alloimmunization Foundation, The Allo Hope Foundation

ResearchLimited published research (7 articles)

Diagnosis

Biomarker and diagnostic research for congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunization has been reported in the published literature.

Prognosis

Estimated prevalence: <1 in 1,000,000 (VERY_RARE).

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunization.

7 publications have been identified in PubMed for congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunization. Research spans Diagnostic / Biomarker (43%), Review / Meta-Analysis (29%), and Epidemiology / Natural History (29%).

Recent Publications

Bhimma R (2026). [PMID: 41100440](https://pubmed.ncbi.nlm.nih.gov/41100440/). *Nephron*. [Diagnostic / Biomarker]
Hannoun P (2026). [PMID: 42217663](https://pubmed.ncbi.nlm.nih.gov/42217663/). *Am J Obstet Gynecol*. [Epidemiology / Natural History]
Veiga-Canuto D (2026). [PMID: 42050293](https://pubmed.ncbi.nlm.nih.gov/42050293/). *Eur Radiol*. [Diagnostic / Biomarker]
Fassett MJ (2025). [PMID: 40245931](https://pubmed.ncbi.nlm.nih.gov/40245931/). *Am J Perinatol*. [Epidemiology / Natural History]
Kelgeri C (2024). [PMID: 39151605](https://pubmed.ncbi.nlm.nih.gov/39151605/). *J Pediatr*. [Review / Meta-Analysis]

Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 9:49 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Patient Support

Patient Advocacy Groups

View all PAGs →

Maternal Alloimmunization FoundationPrimary Focus

USWebsite ↗

The Allo Hope FoundationPrimary Focus

USWebsite ↗

Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.

Are you a patient organization not listed here? Claim this page to be listed and embed this content on your site — free.

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:69063

GARD

Genetic and Rare Diseases Info Center

GARD:18896

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→How can I connect with Maternal Alloimmunization Foundation and other patient organizations for support?

← Back to All Diseases

congenital membranous nephropathy due to maternal anti-neutral endopeptidase alloimmunization

Overview

Diagnosis

Prognosis

Research Landscape

Recent Publications

Patient Support

Patient Advocacy Groups

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team